Which has the lower trailing P/E, DMAA or FACT?

FACT has the lower trailing P/E: DMAA trades at 55.53 and FACT at 54.06. P/E is one valuation measure and does not by itself establish which business is cheaper.

Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) vs FACT II Acquisition Corp (FACT)

A side-by-side comparison of Drugs Made In America Acquisition Corp. Ordinary Shares and FACT II Acquisition Corp across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

DMAA

Drugs Made In America Acquisition Corp. Ordinary Shares

$265M

$10.90Financial ServicesDelayed quote: Oct 5, 2026, 1:49 PM EDT

FACT

FACT II Acquisition Corp

$261M

$10.73Financial ServicesDelayed quote: Oct 5, 2026, 3:59 PM EDT

Total return — DMAA vs FACT

growth of $100 · dividends reinvested · last 2y

DMAA +9.3% (+4.6%/yr)FACT +7.5% (+3.7%/yr)DMAA compounded faster over this window

DMAA FACT

DMAA vs FACT: by the numbers

•DMAA is the larger company ($265M vs $261M market cap).
•FACT trades at the lower trailing earnings multiple (54.06 vs 55.53 P/E), one valuation lens rather than an overall verdict.

Metrics side by side

Valuation

Metric	DMAA	FACT
P/E ratio	55.53	54.06
P/B ratio	1.92	1.47

Profitability

Metric	DMAA	FACT
Gross margin	0.00%	0.00%
Operating margin	0.00%	0.00%
Net margin	0.00%	0.00%
ROE	4.42%	2.16%
ROIC	-1.82%	-1.54%

Frequently asked

Which has the lower trailing P/E, DMAA or FACT?: FACT has the lower trailing P/E: DMAA trades at 55.53 and FACT at 54.06. P/E is one valuation measure and does not by itself establish which business is cheaper.

Go deeper

Full DMAA analysis Full FACT analysis Interactive comparison tool

Dig into the metrics

Drugs Made In America Acquisition Corp. Ordinary Shares P/E ratio FACT II Acquisition P/E ratio Drugs Made In America Acquisition Corp. Ordinary Shares ROE FACT II Acquisition ROE Drugs Made In America Acquisition Corp. Ordinary Shares operating margin FACT II Acquisition operating margin Drugs Made In America Acquisition Corp. Ordinary Shares revenue growth FACT II Acquisition revenue growth Drugs Made In America Acquisition Corp. Ordinary Shares free cash flow FACT II Acquisition free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.